Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
View ORCID ProfileErik Jue, View ORCID ProfileRustem F. Ismagilov
doi: https://doi.org/10.1101/2020.04.28.20077602
Erik Jue
aDivision of Biology and Biological Engineering
Rustem F. Ismagilov
aDivision of Biology and Biological Engineering
bDivision of Chemistry and Chemical Engineering
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted May 04, 2020.
Commercial stocks of SARS-CoV-2 RNA may report low concentration values, leading to artificially increased apparent sensitivity of diagnostic assays
Erik Jue, Rustem F. Ismagilov
medRxiv 2020.04.28.20077602; doi: https://doi.org/10.1101/2020.04.28.20077602
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (648)
- Anesthesia (174)
- Cardiovascular Medicine (2491)
- Dermatology (209)
- Emergency Medicine (384)
- Epidemiology (11957)
- Forensic Medicine (10)
- Gastroenterology (715)
- Genetic and Genomic Medicine (3884)
- Geriatric Medicine (359)
- Health Economics (648)
- Health Informatics (2507)
- Health Policy (968)
- Hematology (350)
- HIV/AIDS (813)
- Medical Education (386)
- Medical Ethics (106)
- Nephrology (414)
- Neurology (3641)
- Nursing (205)
- Nutrition (542)
- Oncology (1888)
- Ophthalmology (552)
- Orthopedics (230)
- Otolaryngology (299)
- Pain Medicine (240)
- Palliative Medicine (71)
- Pathology (461)
- Pediatrics (1069)
- Primary Care Research (434)
- Public and Global Health (6313)
- Radiology and Imaging (1336)
- Respiratory Medicine (845)
- Rheumatology (388)
- Sports Medicine (333)
- Surgery (425)
- Toxicology (51)
- Transplantation (179)
- Urology (154)